These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 17309819)

  • 21. Murine KIT+ lineage- bone marrow progenitors express Fc gamma-RII but do not express Fc epsilon-RI until mast cell granule formation.
    Lantz CS; Huff TF
    J Immunol; 1995 Jan; 154(1):355-62. PubMed ID: 7527815
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Demonstration of differential effects of cytokines on mast cells derived from murine bone marrow and peripheral blood mononuclear cells.
    Rottem M; Hull G; Metcalfe DD
    Exp Hematol; 1994 Nov; 22(12):1147-55. PubMed ID: 7523167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IL-3-mediated TNF production is necessary for mast cell development.
    Wright HV; Bailey D; Kashyap M; Kepley CL; Drutskaya MS; Nedospasov SA; Ryan JJ
    J Immunol; 2006 Feb; 176(4):2114-21. PubMed ID: 16455967
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cultured human intestinal mast cells express functional IL-3 receptors and respond to IL-3 by enhancing growth and IgE receptor-dependent mediator release.
    Gebhardt T; Sellge G; Lorentz A; Raab R; Manns MP; Bischoff SC
    Eur J Immunol; 2002 Aug; 32(8):2308-16. PubMed ID: 12209644
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD154 induces a switch in pro-survival Bcl-2 family members in chronic lymphocytic leukaemia.
    Willimott S; Baou M; Naresh K; Wagner SD
    Br J Haematol; 2007 Sep; 138(6):721-32. PubMed ID: 17760804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IL-3-dependent murine mast cells undergo apoptosis on removal of IL-3. Prevention of apoptosis by c-kit ligand.
    Mekori YA; Oh CK; Metcalfe DD
    J Immunol; 1993 Oct; 151(7):3775-84. PubMed ID: 7690814
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IgE-receptor activation induces survival and Bfl-1 expression in human mast cells but not basophils.
    Xiang Z; Möller C; Nilsson G
    Allergy; 2006 Sep; 61(9):1040-6. PubMed ID: 16918505
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Costimulation with interleukin-4 and interleukin-10 induces mast cell apoptosis and cell-cycle arrest: the role of p53 and the mitochondrion.
    Bouton LA; Ramirez CD; Bailey DP; Yeatman CF; Yue J; Wright HV; Domen J; Rosato RR; Grant S; Fischer-Stenger K; Ryan JJ
    Exp Hematol; 2004 Dec; 32(12):1137-45. PubMed ID: 15588938
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Roles of MITF for development of mast cells in mice: effects on both precursors and tissue environments.
    Morii E; Oboki K; Ishihara K; Jippo T; Hirano T; Kitamura Y
    Blood; 2004 Sep; 104(6):1656-61. PubMed ID: 15172970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The apoptosis and proliferation of SAC-activated B cells by IL-10 are associated with changes in Bcl-2, Bcl-xL, and Mcl-1 expression.
    Li L; Krajewski S; Reed JC; Choi YS
    Cell Immunol; 1997 May; 178(1):33-41. PubMed ID: 9184696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preferential expression of interleukin-12 or interleukin-4 by murine bone marrow mast cells derived in mast cell growth factor or interleukin-3.
    Smith TJ; Ducharme LA; Weis JH
    Eur J Immunol; 1994 Apr; 24(4):822-6. PubMed ID: 7512032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines.
    Nuñez G; London L; Hockenbery D; Alexander M; McKearn JP; Korsmeyer SJ
    J Immunol; 1990 May; 144(9):3602-10. PubMed ID: 2184193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An optimized protocol for the generation and functional analysis of human mast cells from CD34
    Yin Y; Bai Y; Olivera A; Desai A; Metcalfe DD
    J Immunol Methods; 2017 Sep; 448():105-111. PubMed ID: 28629733
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression of the antiapoptotic protein A1 promotes the survival of double positive thymocytes awaiting positive selection.
    Verschelde C; Michonneau D; Trescol-Biemont MC; Berberich I; Schimpl A; Bonnefoy-Berard N
    Cell Death Differ; 2006 Jul; 13(7):1213-21. PubMed ID: 16294210
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of human mast cells through stem cell factor receptor (KIT) is associated with expression of bcl-2.
    Baghestanian M; Jordan JH; Kiener HP; Bevec D; Agis H; Fritsch G; Müller MR; Bankl HC; Schernthaner GH; Lechner K; Valent P
    Int Arch Allergy Immunol; 2002 Nov; 129(3):228-36. PubMed ID: 12444320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FcepsilonRI aggregation promotes survival of connective tissue-like mast cells but not mucosal-like mast cells.
    Ekoff M; Strasser A; Nilsson G
    J Immunol; 2007 Apr; 178(7):4177-83. PubMed ID: 17371974
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nerve growth factor induces the expression of certain cytokine genes and bcl-2 in mast cells. Potential role in survival promotion.
    Bullock ED; Johnson EM
    J Biol Chem; 1996 Nov; 271(44):27500-8. PubMed ID: 8910334
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A p38 inhibitor allows to dissociate differentiation and apoptotic processes triggered upon LIF withdrawal in mouse embryonic stem cells.
    Duval D; Malaisé M; Reinhardt B; Kedinger C; Boeuf H
    Cell Death Differ; 2004 Mar; 11(3):331-41. PubMed ID: 14685156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The BH3-mimetic ABT-737 induces mast cell apoptosis in vitro and in vivo: potential for therapeutics.
    Karlberg M; Ekoff M; Huang DC; Mustonen P; Harvima IT; Nilsson G
    J Immunol; 2010 Aug; 185(4):2555-62. PubMed ID: 20639495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional expression of high-affinity receptor for immunoglobulin E on mast cells precedes that of tryptase during differentiation from human bone marrow-derived CD34 progenitors cultured in the presence of stem cell factor and interleukin-6.
    Shimizu Y; Suga T; Maeno T; Aoki F; Tsukagoshi H; Kawata T; Sakai K; Narita T; Takahashi T; Ishikawa S; Morishita Y; Nakajima T; Hara F; Miura T; Kurabayashi M
    Clin Exp Allergy; 2004 Jun; 34(6):917-25. PubMed ID: 15196280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.